Olanzapine-induced vasculitis

American Journal Geriatric Pharmacotherapy

Volumn 3, Issue 1, 2005, Pages 21-24

  Duggal, Mahesh K ^a   Singh, Amritpal ^b   Arunabh, ^c   Lolis, James D ^c   Guzik, Howard J ^c  

^a Wills Memorial Hospital Washington   (United States)

^b Gerber Hospital Fremont   (United States)

^c NORTH SHORE UNIVERSITY HOSPITAL   (United States)

Author keywords

Adverse drug reaction; Elderly patients; Lenkocytoclastic vasculitis; Multiple medications; Olanzapine

Indexed keywords

DONEPEZIL; ENOXAPARIN; LISINOPRIL; OLANZAPINE; PARACETAMOL; QUETIAPINE; RISPERIDONE; WARFARIN;

AGED; AGITATION; ARTICLE; ARTIFICIAL VENTILATION; BLEEDING; CASE REPORT; CELLULAR IMMUNITY; DELIRIUM; DIZZINESS; DRUG ERUPTION; DRUG WITHDRAWAL; ECCHYMOSIS; ERYTHEMA; FEMALE; HOSPITALIZATION; HUMAN; HUMAN TISSUE; HUMORAL IMMUNITY; IMMUNOPATHOGENESIS; INTERNATIONAL NORMALIZED RATIO; LEUKOCYTOCLASTIC VASCULITIS; LUNG EMBOLISM; PETECHIA; PRIORITY JOURNAL; RECURRENT DISEASE; SKIN BIOPSY; SUBCUTANEOUS TISSUE;

AGED; AGED, 80 AND OVER; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; DELIRIUM; DRUG ERUPTIONS; FEMALE; HUMANS; PULMONARY EMBOLISM; RESPIRATION, ARTIFICIAL; SKIN; VASCULITIS, HYPERSENSITIVITY;

EID: 23744506850     PISSN: 15435946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjopharm.2005.03.003     Document Type: Article

References (17)

1. Lazarou J. Pomeranz B.H. Corey P.N. Incidence of adverse drug reactions in hospitalized patients: A meta-analysis of prospective studies JAMA 279 1998 1200-1205
2. Barranco P. Lopez-Serrano M.C. General and epidemiological aspects of allergic drug reactions Clin Exp Allergy 28 Suppl 4 1998 61-62
3. Naranjo C.A. Busto U. Sellers E.M. et al. A method for estimating the probability of adverse drug reactions Clin Pharmacol Ther 30 1981 239-245
4. Doyle M.K. Cuellar M.L. Drug-induced vascufitis Expert Opin Drug Saf. 2 2003 401-409
5. Schapira D. Balbir-Gurman A. Nahir A.M. Naproxeninduced leukocytoclastic vasculitis Clin Rheumatal 19 2000 242-244
6. Davidson K.A. Ringpfeil F. Lee J.B. Ibuprofen-induced bullous leukocytoclastic vasculitis Cutis 67 2001 303-307
7. Koutkia P. Mylonakis E. Rounds S. Erickson A. Cutaneous leukocytoclastic vasculitis associated with oxacillin Diagn Microbial Infect Dis 39 2001 191-194
8. Poon D.Y. Law N.M. A case of cutaneous leukocytoclastic vascufitis associated with gabapentin Singapore Med J 44 2003 42-44
9. Mohan N. Edwards E.T. Cupps T.R. et al. Leukocytoclastic vasculitis associated with tumor necrosis factor-alpha blocking agents J Rheumatal 31 2004 1955-1958
10. Russell J.P. Weenig R.H. Primary cutaneous small vessel vasculitis Curr Treat Options Cardiovasc Med 6 2004 139-149
11. Zax R.H. Hodge S.J. Callen J.P. Cutaneous leukocytoclastic vasculitis. Serial histopathologic evaluation demonstrates the dynamic nature of the infiltrate Arch Dermatol 126 1990 69-72
12. Crowson A.N. Brown T.J. Magro C.M. Progress in the understanding of the pathology and pathogenesis of cutaneous drug eruptions: Implications for management Am J Clin Dermatol 4 2003 407-428
13. Bachot N. Roujeau J.C. Differential diagnosis of severe cutaneous drug eruptions Am J Clin Dermatol 4 2003 561-572
14. Joint Task Force on Practice Parameters of the American Academy of Allergy, Asthma and Immunology, and the Joint Council of Allergy, Asthma and Immunology Executive summary of disease management of drug hypersensitivity: A practice parameter Ann Allergy Asthma Immunol 83 1999 665-700
15. Street J.S. Clark W.S. Gannon K.S. et al. for the HGEU Study Group Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer's disease in nursing care facilities: A double-blind, randomized, placebocontrolled trial Arch Gen Psychiatry 57 2000 968-976
16. Hagg S. Tatting P. Spigset O. Olanzapine and venous thromboembolism Int Clin Psychopharmacol 18 2003 299-300
17. Adams B.B. Mutasim D.E. Pustular eruption induced by olanzapine, a novel antipsychotic agent J Am Acad Dermatol 41 1999 851-853